Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ProctoFiz is a multi-ingredient herbal topical ointment developed by Sheba Medical Center and Tel Aviv University for the treatment of chronic anal fissure. The formulation is primarily composed of hemp seed oil, which interacts with the endocannabinoid system (ECS) to provide analgesic, anti-inflammatory, and tissue-healing properties. Additional botanical components include calendula, sweet almond, myrtle, arnica, and seaweed extract. Marketed as a medical device in Israel, ProctoFiz has demonstrated significant symptom improvement in clinical studies, showing comparable or superior efficacy to standard nifedipine-lidocaine treatments for anal fissure healing and pain relief.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ProctoFiz.